
ADMA
Healthcare · Biotechnology · $3.03B market cap
$13.68+0.44 (+3.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -5.5% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | After the close | 0.19 | 0.22 | +15.8% |
| Aug 5, 2026 | After the close | 0.16 | 0.16 | 0.0% |
| May 6, 2026 | After the close | 0.20 | 0.17 | -15.0% |
| Mar 19, 2026 | Time not confirmed | 0.19 | 0.22 | +15.5% |
| Nov 5, 2025 | After the close | 0.16 | 0.16 | 0.0% |
| Aug 6, 2025 | After the close | 0.14 | 0.14 | 0.0% |
| May 7, 2025 | After the close | 0.17 | 0.11 | -35.3% |
| Feb 26, 2025 | Before the open | 0.14 | 0.14 | -6.2% |
| Nov 7, 2024 | After the close | 0.13 | 0.15 | +15.4% |
| Aug 8, 2024 | After the close | 0.08 | 0.13 | +62.5% |
| May 9, 2024 | After the close | 0.06 | 0.08 | +33.3% |
| Feb 28, 2024 | After the close | 0.02 | 0.04 | +100.0% |
| Nov 8, 2023 | After the close | -0.01 | 0.01 | +200.0% |
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the…
| Aug 9, 2023 | After the close | -0.02 | -0.02 | 0.0% |
| May 10, 2023 | After the close | -0.04 | -0.03 | +25.0% |
| Mar 23, 2023 | After the close | -0.06 | -0.06 | 0.0% |
| Nov 9, 2022 | After the close | -0.07 | -0.08 | -14.3% |
| Aug 10, 2022 | After the close | -0.08 | -0.07 | +12.5% |
| May 11, 2022 | After the close | -0.08 | -0.09 | -12.5% |
| Mar 24, 2022 | After the close | -0.09 | -0.09 | 0.0% |
| Nov 10, 2021 | After the close | -0.14 | -0.13 | +7.1% |
| Aug 11, 2021 | After the close | -0.15 | -0.14 | +6.7% |
| May 12, 2021 | After the close | -0.16 | -0.16 | 0.0% |
| Mar 25, 2021 | After the close | -0.16 | -0.20 | -25.0% |
| Nov 5, 2020 | After the close | -0.19 | -0.19 | 0.0% |
| Aug 5, 2020 | After the close | -0.16 | -0.23 | -43.8% |
| May 6, 2020 | After the close | -0.11 | -0.26 | -136.4% |
| Mar 12, 2020 | After the close | -0.17 | -0.18 | -5.9% |
| Nov 6, 2019 | After the close | -0.22 | -0.19 | +13.6% |
| Aug 8, 2019 | Before the open | -0.31 | -0.25 | +19.4% |
| May 8, 2019 | After the close | -0.32 | -0.32 | 0.0% |
| Mar 13, 2019 | After the close | -0.33 | -0.39 | -18.2% |
| Nov 8, 2018 | After the close | -0.33 | -0.33 | 0.0% |
| Aug 10, 2018 | Before the open | -0.33 | -0.35 | -6.1% |
| May 14, 2018 | After the close | -0.31 | -0.39 | -25.8% |
| Mar 5, 2018 | Before the open | -0.31 | -0.29 | +6.5% |